A randomized phase II trial of pre-chemotherapy leukine [sargramostim] vs leukine-dexamethasone in combination with gemcitabine and 5-fluorouracil in patients with metastatic renal cell carcinoma.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Dexamethasone; Fluorouracil; Folinic acid; Gemcitabine; Sargramostim
- Indications Renal cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 21 Aug 2006 Status change
- 01 Nov 2005 New trial record.